Weber, Heike 19XX-
Heike Weber
VIAF ID: 7163270994512141046 (Personal)
Permalink: http://viaf.org/viaf/7163270994512141046
Preferred Forms
- 100 0 _ ‡a Heike Weber
- 100 1 _ ‡a Weber, Heike ‡d 19XX-
4xx's: Alternate Name Forms (3)
Works
Title | Sources |
---|---|
Acetylcholine-metabolizing butyrylcholinesterase (BCHE) copy number and single nucleotide polymorphisms and their role in attention-deficit/hyperactivity syndrome. | |
Allelic variation in CRHR1 predisposes to panic disorder: evidence for biased fear processing. | |
Anxiety risk SNPs on chromosome 2 modulate arousal in children in a fear generalization paradigm | |
Association of NPSR1 gene variation and neural activity in patients with panic disorder and agoraphobia and healthy controls | |
Association of polygenic risk scores, traumatic life events and coping strategies with war-related PTSD diagnosis and symptom severity in the South Eastern Europe (SEE)-PTSD cohort | |
Behavioural and functional evidence revealing the role of RBFOX1 variation in multiple psychiatric disorders and traits | |
A common CDH13 variant is associated with low agreeableness and neural responses to working memory tasks in ADHD | |
CRHR1 promoter hypomethylation: An epigenetic readout of panic disorder? | |
DIRAS2 is associated with adult ADHD, related traits, and co-morbid disorders | |
Does prior traumatization affect the treatment outcome of CBT for panic disorder? The potential role of the MAOA gene and depression symptoms. | |
Exploring the contribution to ADHD of genes involved in Mendelian disorders presenting with hyperactivity and/or inattention | |
The functional -1019C/G HTR1A polymorphism and mechanisms of fear. | |
A functional genetic variation of SLC6A2 repressor hsa-miR-579-3p upregulates sympathetic noradrenergic processes of fear and anxiety | |
Functional Impact of An ADHD-Associated DIRAS2 Promoter Polymorphism. | |
Funktionelle Genetik der Panikstörung und Agoraphobie | |
Gender differences in associations of glutamate decarboxylase 1 gene (GAD1) variants with panic disorder | |
The genetic contribution of the NO system at the glutamatergic post-synapse to schizophrenia: further evidence and meta-analysis. | |
Genetic variation in the choline O-acetyltransferase gene in depression and Alzheimer's disease: the VITA and Milano studies | |
A genome-wide association meta-analysis of prognostic outcomes following cognitive behavioural therapy in individuals with anxiety and depressive disorders | |
Genome-wide association study of panic disorder reveals genetic overlap with neuroticism and depression | |
Identification of ADHD risk genes in extended pedigrees by combining linkage analysis and whole-exome sequencing | |
Influence of 5-HTT variation, childhood trauma and self-efficacy on anxiety traits: a gene-environment-coping interaction study. | |
The interaction of early life experiences with COMT val158met affects anxiety sensitivity | |
Knockdown of the ADHD Candidate Gene Diras2 in Murine Hippocampal Primary Cells | |
Lithium-induced gene expression alterations in two peripheral cell models of bipolar disorder. | |
MAOA and mechanisms of panic disorder revisited: from bench to molecular psychotherapy. | |
Meta-analysis argues for a female-specific role of MAOA-uVNTR in panic disorder in four European populations | |
Meta-analysis of the DRD5 VNTR in persistent ADHD. | |
MicroRNA hsa-miR-4717-5p regulates RGS2 and may be a risk factor for anxiety-related traits | |
Multi-level biomarker analysis of nitric oxide synthase isoforms in bipolar disorder and adult ADHD. | |
Neuropeptide S receptor gene -- converging evidence for a role in panic disorder. | |
Neuropeptide S receptor gene: fear-specific modulations of prefrontal activation. | |
Orexin in the anxiety spectrum: association of a HCRTR1 polymorphism with panic disorder/agoraphobia, CBT treatment response and fear-related intermediate phenotypes | |
A preliminary study on methylphenidate-regulated gene expression in lymphoblastoid cells of ADHD patients | |
A regulator gene with an impact: RBFOX1 and its role in neuropsychiatric disorders | |
Shared genetic background between children and adults with attention deficit/hyperactivity disorder | |
SLC2A3 single-nucleotide polymorphism and duplication influence cognitive processing and population-specific risk for attention-deficit/hyperactivity disorder. | |
SPOCK3, a risk gene for adult ADHD and personality disorders |